SINGAPORE, June 25, 2021 /PRNewswire/ — CYFIRMA, a threat discovery and cyber-intelligence platform company, funded by Goldman Sachs, Zodius Capital and Z3Partners, today announced that Zuellig Pharma, a leading healthcare services provider in Asia, has selected DeCYFIR, a cloud-based, AI-powered cybersecurity platform, to gain further visibility into its external threat landscape to uncover hacking campaigns and avert cyberattacks.
In the last 18 months, the COVID-19 pandemic has seen the global healthcare industry falling victim to cybercriminals taking advantage of the chaos. According to CYFIRMA researchers, cyberattacks on healthcare more than doubled in 2020. COVID-19 response efforts, including vaccine research and supply chain were the largest focus of these targeted campaigns.
With CYFIRMA’s DeCYFIR platform, Zuellig Pharma has bolstered its cyber defence ammunition to accurately uncover cyberattacks at the early planning stage and take remedial actions to close vulnerabilities before hackers can compromise the network. The platform enables further visibility into the external threat landscape by monitoring the dark web, hacker forums and various closed communities…
